Contact this trialFirst, we need to learn more about you.
Beta-lactamase inhibitor
ATM-AVI for Bacterial Infections
Recruiting1 awardPhase 2
New York, New York
This trial is studying the safety/effectiveness of ATM/AVI as a treatment for children with serious infections. They will be given an intravenous dose based on weight/kidney function, and may be switched to oral therapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.